Emma L. Plested
Impact in
- Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Outbreaks Research
- Modeling and Simulation top 0.5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 25
- Viral Infections and Outbreaks Research 3
-
- Bacterial Infections and Vaccines 7
- Co-authors
- Matthew D. Snape (10 shared papers)Nick J Andrews (3 shared papers)Elizabeth J. Miller (3 shared papers)David Goldblatt (3 shared papers)Joanne (Jo) Southern (3 shared papers)Lucy Roalfe (2 shared papers)Polly Burbidge (1 shared paper)Hannah Robinson (5 shared papers)
- Journals
- The Lancet (7 papers)Journal of Infection (4 papers)Nature Medicine (3 papers)The Lancet Infectious Diseases (3 papers)JAMA (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Emma L. Plested
44 papers receiving 10.2k citations
Emma L. Plested's Hit Papers
Peers
Comparison fields: 5 of 130
- Infectious Diseases 8k
- Modeling and Simulation 377
- Health 505
- Toxicology 118
- Virology 97
Countries citing papers authored by Emma L. Plested
This map shows the geographic impact of Emma L. Plested's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma L. Plested with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma L. Plested more than expected).
Fields of papers citing papers by Emma L. Plested
This network shows the impact of papers produced by Emma L. Plested. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma L. Plested. The network helps show where Emma L. Plested may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma L. Plested, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3698 |
| 2 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1939 |
| 3 | Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection Hit paper breakdown → | 2021 | 897 |
| 4 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 5 | 2020 | 481 | |
| 6 | Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Hit paper breakdown → | 2021 | 477 |
| 7 | Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Hit paper breakdown → | 2021 | 405 |
| 8 | Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines Hit paper breakdown → | 2016 | 278 |
| 9 | 2020 | 257 | |
| 10 | 2021 | 192 | |
| 11 | 2021 | 186 | |
| 12 | 2021 | 181 | |
| 13 | 2022 | 138 | |
| 14 | 2017 | 96 | |
| 15 | 2021 | 44 | |
| 16 | 2022 | 39 | |
| 17 | 2022 | 38 | |
| 18 | 2020 | 34 | |
| 19 | 2022 | 32 | |
| 20 | 2022 | 31 |
About Emma L. Plested
Emma L. Plested is a scholar working on Infectious Diseases, Microbiology, Epidemiology, Food Science and Virology, having authored 46 papers that have together received 10.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (25 papers), Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (7 papers), Viral Infections and Outbreaks Research (3 papers), Salmonella and Campylobacter epidemiology (2 papers), Ethics in Clinical Research (1 paper), Respiratory viral infections research (1 paper) and Poxvirus research and outbreaks (1 paper). The work is most often cited by research in Infectious Diseases (8k citations), Modeling and Simulation (377 citations), Health (505 citations), Toxicology (118 citations) and Virology (97 citations). Emma L. Plested has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Matthew D. Snape, Nick J Andrews, Elizabeth J. Miller, David Goldblatt, Joanne (Jo) Southern, Lucy Roalfe, Polly Burbidge, Hannah Robinson, Merryn Voysey and Ray Borrow. Their work appears in journals such as The Lancet, Journal of Infection, Nature Medicine, The Lancet Infectious Diseases and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.